Pharmaceutical promotion: how does it impact rational use of medicine?

Europe Faces a Critical Time of Key Medicine Shortages Amidst a Pandemic

What do the next five years have in store for the European Medicines Agency?

COVID-19 exposes weak health systems

Dutch institutions failing to register results of clinical trials

COVID-19 and Snakebite: Including the voices of our most marginalised

The significant impact of Health Technology Assessment discussions on national health systems

COVID-19 risks turning back the clock on years of essential development work

Barriers and facilitators of access to Internationally Controlled Essential Medicines in Kenya

HAI Releases Annual Report 2019

Clinical trials and COVID-19

Reflections on the World Health Assembly

COVID-19 And Its Far-Reaching Health Impacts in Sub-Saharan Africa

Why TRIPS flexibilities are a crucial mechanism for access to medicines

EU Must Not Miss its Chance on WHO Technology Pool

TRIPS-flexibilities in Health Crises and Beyond

In defence of WHO

The hidden impact of COVID-19 on sexual and reproductive health

Community measures to prevent snakebite during COVID-19

Reversed gains in the advancement of SRHR in Kenya; effects of COVID-19

To tackle COVID-19 pandemic, transparency and collaboration are vital

COVID-19, social determinants and frontline workers

Health Action International Working from Home

Ensure transparency, affordability and availability of vaccines and treatments for COVID-19, say MEPs

HAI Follows Dutch Government Advice in Response to COVID-19

HAI Recognised for Commitment to Gender Equality

Europe’s Beating Cancer Plan

Niets magisch aan medicijnprijzen

Nothing magical about medicine prices

US puts pressure on the Netherlands over compulsory licenses